— Know what they know.
Not Investment Advice

0239.HK HKSE

Pak Fah Yeow International Limited
1W: +3.4% 1M: -5.8% 3M: +2.9% YTD: +2.1% 1Y: +0.8% 3Y: +81.5% 5Y: +80.2%
HK$2.48 ($0.32)
+0.00 (+0.00%)
 
Weekly Expected Move ±3.2%
HK$2 HK$2 HK$2 HK$3 HK$3
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 56 · HK$763.5M mcap · 120M float · 0.029% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market CapHK$763.5M ($97.3M)
52W Range2.24-2.73
Volume10,000
Avg Volume35,011
Beta0.40
DividendHK$0.19
Analyst Ratings
No analyst coverage
Company Info
CEOWee Sean Gan
Employees100
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date1991-12-18
200 Gloucester Road
Hong Kong
HK
852 2881 7713
About Pak Fah Yeow International Limited

Pak Fah Yeow International Limited, operating with its subsidiaries, specializes in the production, promotion, and distribution of healthcare goods under the Hoe Hin brand. Its market reach spans the People's Republic of China, Hong Kong, Macau, Southeast Asia, North America, the United Kingdom, and other international territories. The company's operations are categorized into three distinct divisions: Healthcare, Property Investments, and Treasury Investments. Among its key offerings are medicated oils, such as white flower embrocation, along with various ointments and solutions for strain relief, including the floral-scented Fúzai 239 white flower embrocation. Beyond its primary healthcare focus, the firm also commits capital to diverse real estate assets, encompassing commercial, industrial, residential, and car park properties, and additionally provides advertising agency services. This enterprise, established in 1927, maintains its corporate headquarters in Wan Chai, Hong Kong.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms